Home › Resources › Inside Citeline PatientMatch: How AI Precision Finds Patients Who Fit Your Protocol
What sets our approach to patient matching apart from standard solutions?
Patient matching now features in most recruitment plans, and clinical operations teams are asking sharper questions about it. In this 30-minute session, our experts answer that question and show how Citeline AI and real-world data find patients who match a trial protocol.
Complete the form to watch the recording.
Choose a time to talk
Calendar requires cookies. Enable cookies
Or send us a message and we'll be in touch
Rahul Das
SVP, AI & Life Sciences Solutions
View profile

SVP, AI & Life Sciences Solutions
Norstella
Rahul is a computational scientist with around two decades of experience extracting useful signals from complex datasets, from proteins and molecular systems through cancer genomics and unstructured clinical records. At Norstella he has applied this experience to production AI that extracts clinically relevant information from unstructured notes and supports disease-specific datasets, predictive triggers, and patient-identification capabilities.
What makes Norstella's AI different?
Two things: data and people. Norstella combines multimodal real-world data such as clinical notes, EHR, claims, and genomics with data scientists, engineers, clinical specialists, and human-in-the-loop validation. AI is therefore developed against deep healthcare information and evaluated using expert-reviewed samples rather than operating without domain oversight.
What can pharma teams do now that was not possible two years ago?
Teams can identify relevant patient populations and characterize disease progression using clinical information buried in unstructured and multimodal data, at population scale and close to real time. Questions that previously depended on manual chart review or retrospective studies can increasingly be answered on demand.
How can AI accelerate the journey from pipeline to patient?
Richer real-world datasets and advances in LLMs and agentic AI make it possible to identify signals and assemble complex insights much faster. Domain expertise remains necessary to direct these technologies appropriately and ensure outputs are reliable enough to support pharmaceutical decisions.
Lindsay Stahl
VP, Global Head of Patient Engagement and Recruitment
View profile

VP, Global Head of Patient Engagement and Recruitment
Citeline
Lindsay leads Citeline's Patient Engagement and Recruitment division and is responsible for helping guide, grow, and deliver on our Patient Engagement and Recruitment solutions. She has over 15 years of experience in scientific and clinical research & development, and real-world data strategy and solutioning for clinical investigation.
Lindsay leads Citeline's Patient Engagement and Recruitment division and is responsible for helping guide, grow, and deliver on our Patient Engagement and Recruitment solutions. She has over 15 years of experience in scientific and clinical research & development, and real-world data strategy and solutioning for clinical investigation.
Lindsay holds an MS in Epidemiology from Columbia University, an MA in Biopsychology from the City University of New York, Hunter, and a BA in Psychology from the University of Rhode Island
Skye Hodson, PhD
Vice President, Clinical Solutions
View profile

Vice President, Clinical Solutions
Citeline
Skye is a Biochemist with over 10 years of life sciences CRO and CCO experience, delivering tangible business outcomes across strategy, product development, clinical operations, commercialization and growth. He focuses on leveraging enabling technologies to accelerate the development of new medicines, having seen firsthand how data-driven insights and advanced analytics/AI can unlock real value for patients and companies. He is passionate about disrupting the status quo and advancing holistic health agendas, engaging with the community as a speaker, mentor and advocate for innovation in life sciences.